Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Mark Terry… Source: BioSpace You Might Also Like Senator Harris Scrutinizes How Alkermes Pushed Its Opioid Addiction Drug November 6, 2017 Debt-Ridden Valeant Nears Sale of Its $2 Billion Eye Care Biz Bausch & Lomb June 6, 2017 Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe January 23, 2018
